TCF7L2 is a transcription factor in the Wnt/β-catenin pathway, best known for strong GWAS associations with type 2 diabetes. The direct link to skin („Haut“) is weak and mostly mechanistic or indirect. Wnt signaling is involved in hair follicle development, wound healing, and epidermal homeostasis. Therefore, TCF7L2 variants could theoretically influence skin regeneration or risk for conditions like psoriasis, but evidence is limited and not replicated. Most research on TCF7L2 focuses on glucose metabolism and beta-cell function. A direct, clinically relevant effect on skin health is not established. Consumer DNA tests reporting TCF7L2 variants should not be interpreted as skin predictors. The evidence level is GWAS-based with mechanistic hints, but lacks strong human studies. Caution is warranted: TCF7L2 is not a skin gene in the strict sense.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-10d9346b3fce4f253d06472a